Your browser doesn't support javascript.
loading
Changes in Kidney Function After Diagnosis of Advanced Heart Failure.
Quiram, Benjamin J; Killian, Jill M; Redfield, Margaret M; Smith, Jamie; Hickson, Latonya J; Schulte, Phillip J; Ngufor, Che; Dunlay, Shannon M.
Afiliação
  • Quiram BJ; Mayo Clinic Alix School of Medicine, Rochester, Minnesota.
  • Killian JM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Redfield MM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Smith J; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
  • Hickson LJ; Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida.
  • Schulte PJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Ngufor C; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota; Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Dunlay SM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota. Electronic address: Dunlay.shannon@mayo.edu.
J Card Fail ; 29(12): 1617-1625, 2023 12.
Article em En | MEDLINE | ID: mdl-37451601
ABSTRACT

BACKGROUND:

Kidney function and its association with outcomes in patients with advanced heart failure (HF) has not been well-defined. METHODS AND

RESULTS:

We conducted a retrospective cohort study comprising all adult residents of Olmsted County, Minnesota, with HF who developed advanced HF from 2007 to 2017. Patients were grouped by estimated glomerular filtration rate (eGFR) at advanced HF diagnosis using the 2021 Chronic Kidney Disease Epidemiology Collaboration equation. A linear mixed effects model was fitted to assess the relationship between development of advanced HF and longitudinal eGFR trajectory. A total of 936 patients with advanced HF (mean age 77 years, 55% male, 93.7% White) were included. Twenty-two percent of these patients had an eGFR of <30 at advanced HF diagnosis, 22% had an eGFR of 30-44, 23% had an eGFR of 45-59, and 32% had an eGFR of ≥60 mL/min/1.73 m2. The eGFR decreased faster after advanced HF (7.6% vs 10.9% annual decline before vs after advanced HF), with greater decreases after advanced HF in those with diabetes and preserved ejection fraction. An eGFR of <30 mL/min/1.73 m2 was associated with worse survival after advanced HF compared with an eGFR of ≥60 mL/min/1.73 m2 (adjusted hazard ratio 1.30, 95% confidence interval 1.07-1.57).

CONCLUSIONS:

eGFR deteriorated faster after patients developed advanced HF. An eGFR of <30 mL/min/1.73 m2 at advanced HF diagnosis was associated with higher mortality.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Revista: J Card Fail Assunto da revista: CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Revista: J Card Fail Assunto da revista: CARDIOLOGIA Ano de publicação: 2023 Tipo de documento: Article